Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study
暂无分享,去创建一个
David J. Brooks | Alan L. Whone | D. Brooks | R. Moore | A. Whone | S. McGowan | Robert Y. Moore | Stephen McGowan
[1] J S Rakshi,et al. Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET , 1998, Journal of neurology, neurosurgery, and psychiatry.
[2] D J Brooks,et al. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. , 1996, Brain : a journal of neurology.
[3] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] D J Brooks,et al. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. , 1996, Brain : a journal of neurology.
[5] D. Marshak. Synaptic inputs to dopaminergic neurons in mammalian retinas. , 2001, Progress in brain research.
[6] K. Jellinger,et al. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.
[7] D. Doudet,et al. 6-18F-DOPA PET study in patients with schizophrenia , 2000, Psychiatry Research: Neuroimaging.
[8] C D Marsden,et al. Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.
[9] P. Thompson,et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system , 1992, Neurology.
[10] P Cumming,et al. Controversies arising from recent FDOPA articles. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] G. Paxinos,et al. THE HUMAN NERVOUS SYSTEM , 1975 .
[12] T. Spinks,et al. Physical characteristics of the ECAT EXACT3D positron tomograph. , 2000, Physics in medicine and biology.
[13] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] H. Braak,et al. Nigral and extranigral pathology in Parkinson's disease. , 1995, Journal of neural transmission. Supplementum.
[15] K. Ohtsubo,et al. Pineal gland in old age; quantitative and qualitative morphological study of 168 human autopsy cases , 1987, Brain Research.
[16] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.
[17] K. Jellinger. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? , 1999, Journal of neural transmission. Supplementum.
[18] H. Steinbusch,et al. Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.
[19] B. Berger,et al. Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease , 1991, Annals of neurology.
[20] D L Hill,et al. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. , 1997, Medical physics.
[21] D. J. Brooks,et al. Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease , 2000, Journal of Neurology.
[22] A. Parent,et al. Dopaminergic innervation of human basal ganglia , 2000, Journal of Chemical Neuroanatomy.
[23] C. Crouzel,et al. Presynaptic dopaminergic function in the striatum of schizophrenic patients , 1997, Schizophrenia Research.
[24] F. Fornai,et al. The role of the locus coeruleus in the development of Parkinson's disease , 2000, Neuroscience & Biobehavioral Reviews.
[25] B. Scatton,et al. Parkinson's disease and dementia , 1987, Neurology.
[26] David J Brooks,et al. Plasticity of the nigropallidal pathway in Parkinson's disease , 2003, Annals of neurology.
[27] T. Ishikawa,et al. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] V. Chan‐Palay,et al. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression , 1989, The Journal of comparative neurology.
[29] W D Heiss,et al. Increased pineal Fdopa uptake is related to severity of Parkinson's disease – A PET study , 2001, Journal of pineal research.
[30] M Schulzer,et al. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism , 1994, Annals of neurology.
[31] Alan C. Evans,et al. Dopa decarboxylase activity of the living human brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Nahmias,et al. Dopamine visualized in the basal ganglia of living man , 1983, Nature.
[33] Andrew D. Roberts,et al. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa , 1999, Neurology.
[34] C. Matthews,et al. The pineal gland as an APUD organ: supporting evidence and implications. , 1979, Medical hypotheses.
[35] Alan C. Evans,et al. Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Takeo Ishigaki,et al. Extrastriatal Mean Regional Uptake of Fluorine-18-FDOPA in the Normal Aged Brain—An Approach Using MRI-Aided Spatial Normalization , 2000, NeuroImage.